Safety and Tolerability of Risperidone Implants
NCT02773576 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2020-02-19
Summary
A one year, open-label, study to evaluate the safety and tolerability of risperidone implants as a maintenance treatment in patients with schizophrenia
Conditions
Interventions
- DRUG
-
Risperidone implant
Sponsors & Collaborators
-
Braeburn Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2017-09-30
- Completion
- 2017-09-30
Countries
- United States
Study Locations
More Related Trials
-
A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
NCT00558298 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
NCT00210691 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone
NCT00246272 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia
NCT00236587 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
NCT00563017 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
NCT00253162 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
NCT00236353 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders
NCT01855074 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
NCT00821600 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing Response in Psychosis Study
NCT00314327 ·Status: TERMINATED ·Phase: PHASE4
-
Risperidone Maintenance Treatment in Schizophrenia
NCT00848432 ·Status: COMPLETED ·Phase: PHASE4
-
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
NCT01774435 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Schizophrenia Patients
NCT01086748 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
NCT01677377 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
NCT01552772 ·Status: COMPLETED ·Phase: PHASE1
-
Schizophrenia Study In Adults
NCT00049946 ·Status: COMPLETED ·Phase: PHASE2
-
Risperidone Augmentation in Patients With Schizophrenia
NCT00289861 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
NCT06878833 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.
NCT00495118 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
NCT00257075 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Novel Antipsychotic ITI-007 in Schizophrenia
NCT01499563 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Study of Cariprazine in Patients With Schizophrenia
NCT01104792 ·Status: COMPLETED ·Phase: PHASE3
-
Brexpiprazole in Patients With Schizophrenia
NCT01810783 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes
NCT00132678 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Cariprazine in Patients With Chronic Stable Schizophrenia
NCT00839852 ·Status: COMPLETED ·Phase: PHASE2